Blog Overview

Helicobacter pylori vaccine platform

Helicobacter pylori and Campylobacter spp. are leading causes of gastrointestinal illness worldwide. Existing solutions are limited, and there’s a need for broad-spectrum protection. acib offers a dual-protection vaccine platform using H. pylori to deliver Campylobacter antigens, potentially reducing development time

Continue reading

Protein Engineering Beyond Nature’s Limit

Are you grappling with challenges related to protein stability, activity, expression, or purification? Look no further – the Austrian Centre of Industrial Biotechnology (acib) offers new machine learning and neural network tools to predict better protein variants with unprecedented accuracy.

Continue reading

Green Pharmaceuticals from Lignin

The demand for sustainable and economically viable sources of pharmaceutical compounds is on the rise. Traditional methods rely heavily on petrochemicals, leading to environmental pollution and resource depletion. By utilizing lignin, a major component of biomass, as a starting material

Continue reading

Maximizing Performance of CHO cells

Are you a pharmaceutical company struggling with high production costs for biopharmaceuticals due to limitations of CHO cell lines? Unleash the full potential of your CHO protein production with acib’s stabilizer technology to increase yields.

Continue reading

Microbial Phytosterol Production

Did you know that phytosterols are natural compounds exhibiting a variety of health benefits for humans and pets? There is concern of not getting enough phytosterols from the diet, since the body can’t produce it on its own leading to

Continue reading
No more posts to show